AI in Medical Malpractice in 2026

Table of Contents

An ICU nurse noticed something wasn’t right with a 72 year old patient who had just been discharged. What she didn’t know at the time was that this moment would echo far beyond the bedside.

His doctor had recommended two more weeks of rehabilitation. But, an insurer’s AI system overruled it, leading to coverage sto. Within days, he was back in the emergency room. Within months, his family became part of a federal case against United Health.

This is not a one-off situation anymore. It is a signal of where things are headed.

In 2026, AI liability is no longer a future concern. It is showing up in lawsuits, investigations, and public scrutiny. For healthcare leaders, physicians, and CMIOs, the real question is not whether AI will fail. It is who is accountable when it does.

The Shift: AI Is Now in Production, Not Pilots

Over the past few years, healthcare moved AI from sandbox experiments to everyday clinical workflows. Hospitals now deploy algorithms to read imaging, flag sepsis risk, and manage patient prioritization. Insurance companies use models to drive prior authorization decisions. Regulators have cleared over 1,000 AI-enabled medical devices.

But this scale brings risk at scale.

The UnitedHealth litigation and separate class actions against Cigna (alleging automatic claim denials via the PXDX algorithm) reveal something uncomfortable: when AI is integrated into care and coverage decisions, and those decisions harm patients, the legal system doesn’t yet have clear rules for who pays.

The Liability Trap: Why Doctors Still Own The Malpractice

Despite the algorithmic headlines, malpractice law still starts with a human clinician. Under traditional tort doctrine, courts ask whether a physician acted as a reasonably competent peer would have, given the information available at the time. AI doesn’t change that starting point; it changes the context.

Most malpractice complaints today still name the treating clinician and the institution first. Legal commentary emphasizes that, lack of new statutes, boards and courts continue to treat AI as a tool the physician chose to use or ignore, and not an independent actor. Even in AI‑heavy fact patterns, like a missed diagnosis where both the radiologist and the AI failed to flag a lesion, plaintiffs typically argue that the physician remained responsible for interpreting the study and acting on clinical signs.

Hospitals and vendors too can face claims for negligent selection, validation, or monitoring of AI systems, or for failing to train staff or respond to known performance problems. Vendors can be sued under product‑liability‑style theories if their algorithms are defectively designed, inadequately tested, or misleadingly marketed. But those claims tend to layer on top of, not replace, physician liability.

The result is a “legal vacuum” where everyone talks about AI liability, but in practice, “nobody gets sued but the doctor” remains largely true.

Three New Fault Lines: How AI Reshapes Malpractice Risk

1. Automation Bias: The “AI Penalty”

Study by NEJM AI presents a troubling finding: when jurors see that an AI system detected an abnormality but the radiologist missed it, they’re more likely to find the clinician liable, even if the AI’s overall error rate is publicly known.

This “AI penalty” cuts both ways. Blind trust in algorithms, when other clinical evidence contradicts them, looks like negligence to a jury. But so does ignoring a validated tool’s output.

The message is stark: You can’t hide behind AI when it’s wrong, but you also can’t ignore it when your peers are using it.

2. Under-Use as Risk

As AI becomes standard in specific specialties, not using a widely available, validated tool can now be argued as falling below the standard of care.

Imagine a radiology department where 90% of colleagues use an approved AI system to double-check lung nodules. The radiologist who declines to use it isn’t making a bold individual choice. They’re gradually becoming an outlier, which over timecan become a legal exposure.

3. Algorithmic Bias and Civil Rights Exposure

If an AI model systematically scores certain racial or disability groups as “lower priority” for ICU beds or imaging, institutions face not just malpractice claims but discrimination claims.

This makes bias testing, mitigation, and documentation legally relevant, not just ethically important.

When Payers Deploy AI: Coverage Denial as Care Denial

The nH Predict and PXDX cases highlight a parallel liability vector: payer-side algorithms that override clinical judgment.

In the UnitedHealth litigation, families allege the algorithm cut off skilled nursing coverage prematurely, forcing patients home too soon or into crushing out-of-pocket costs. A Minnesota federal court allowed key claims to move forward and ordered broad discovery into how the tool was designed and governed.

In California, Cigna faces allegations that PXDX was used to auto-deny hundreds of thousands of claims without genuine physician review, potentially violating both state law and plan terms.

Clinically, these cases matter even when doctors aren’t defendants. They show that “the AI said no” can override a physician’s recommendation. When harm follows, courts look back at the clinician’s documentation: What did the doctor recommend? How were risks explained? Did the physician push back?

What Regulators Actually Say in 2026

The FDA maintains a growing list of AI/ML-enabled devices and has issued guidance on bias analysis, performance monitoring, and oversight of adaptive models. But the gap exists: the 21st Century Cures Act carves many clinical decision-support tools out of “medical device” classification, leaving swaths of clinically influential AI effectively unregulated.

One legal principle stands firm: FDA clearance doesn’t determine negligence. Courts still ask whether the clinician acted reasonably with available tools. A hospital with robust AI governance in selection, validation, bias testing, staff training, and monitoring will defend far better than one that simply enabled an algorithm in the EHR and skipped governance.

The Bottom Line

When AI fails in healthcare, it is still your clinicians who end up on the line.

But that doesn’t have to be a threat; it can be a catalyst. The organizations that treat AI as a governed clinical partner will be the ones that both reduce malpractice risk and unlock real performance gains. A full‑pronged AI approach, from model governance to bedside documentation, is ultimately what will make your case win or lose in court.

In 2026, a thoughtful AI strategy is no longer optional; it’s how you protect your people, your patients, and your ability to innovate with confidence.